Back
ESC Premium Access

Differences in long-term all-cause and cardiovascular mortality according to heart failure aetiology in ambulatory patients

Session: Chronic heart failure e-posters
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor G. Spitaleri (Badalona, ES)
Event: ESC Congress 2021 - The Digital Experience

Congress Session

0

About the speaker

Doctor Giosafat Spitaleri

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)
0 follower

218 more presentations in this session

Intermittent therapy with levosimendan in patients with advanced heart failure

Speaker: Professor M. Weis (Munich, DE)

Access
Abstract
Slides
0
Thumbnail

Comparing the central arterial stiffness indices in the decompensated and compensated states of heart failure: a cohort study

Speaker: Assistant Professor G. Youssef (Cairo, EG)

Access
Abstract
Slides
0
Thumbnail

Opportunities for clinician education in the pharmacotherapy of stable heart failure

Speaker: Doctor P. Murray (Dublin, IE)

Access
Abstract
Slides
0
Thumbnail

Systolic blood pressure visit-to-visit variability and clinical outcomes of heart failure with preserved ejection fraction

Speaker: Doctor Q. Zhang (Tianjin, CN)

Access
Abstract
Slides
0
Thumbnail

The risks and benefits of spironolactone use in heart failure with a reduced left ventricular ejection fraction and chronic kidney disease

Speaker: Mrs O. Obertynska (Vinnitsa, UA)

Access
Abstract
Slides
0
Thumbnail

Access the full session

Chronic heart failure e-posters

Speakers: Doctor G. Spitaleri, Professor M. Weis, Assistant Professor G. Youssef, Doctor P. Murray, Doctor Q. Zhang...
Access
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes

27 August 2021

ESC Premium Access

Cardiovascular outcome in patients treated with SGLT2 inhibitors for heart failure: a meta-analysis

27 August 2021

ESC Premium Access

Intermittent therapy with levosimendan in patients with advanced heart failure

27 August 2021

This platform is supported by

logo Novo Nordisk